Cancer Genetics, Inc. Appoints New Member to Board of Directors

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cancer Genetics, Inc. (OTCQB: CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based cancer diagnostics, today announced that its board of directors has increased the board to eight directors and appointed Keith L. Brownlie to serve on the board and its audit committee.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC